Financial results - DIONAMED SRL

Financial Summary - Dionamed Srl
Unique identification code: 29539748
Registration number: J05/23/2012
Nace: 8622
Sales - Ron
291.247
Net Profit - Ron
270.793
Employee
1
The most important financial indicators for the company Dionamed Srl - Unique Identification Number 29539748: sales in 2023 was 291.247 euro, registering a net profit of 270.793 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Dionamed Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 60.892 37.426 37.523 62.721 94.246 75.617 119.415 162.701 160.472 291.247
Total Income - EUR 62.267 39.748 38.714 63.776 94.687 77.724 120.967 163.646 163.323 294.838
Total Expenses - EUR 13.027 13.771 13.001 10.312 20.866 12.085 22.256 6.831 8.309 21.541
Gross Profit/Loss - EUR 49.241 25.978 25.713 53.464 73.821 65.639 98.711 156.815 155.015 273.297
Net Profit/Loss - EUR 47.380 24.817 24.577 52.080 70.992 63.465 95.515 152.493 150.887 270.793
Employees 0 0 0 1 0 0 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 82.0%, from 160.472 euro in the year 2022, to 291.247 euro in 2023. The Net Profit increased by 120.364 euro, from 150.887 euro in 2022, to 270.793 in the last year.

Check the financial reports for the company - Dionamed Srl

Rating financiar

Financial Rating -
Dionamed Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Dionamed Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Dionamed Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Dionamed Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Dionamed Srl - CUI 29539748

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 905 953 491 414 1.007 3.172 9.142 7.031 5.422 3.996
Current Assets 81.265 114.476 43.230 61.330 90.879 149.141 118.921 270.620 259.933 419.203
Inventories 0 0 0 0 402 0 0 0 0 0
Receivables 15.372 11.755 8 451 5.933 956 15.363 947 214.370 977
Cash 65.893 102.721 43.222 60.879 84.544 148.186 103.558 269.673 45.563 418.225
Shareholders Funds 81.798 107.299 24.622 52.132 83.487 134.732 97.123 247.463 150.936 301.039
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 371 8.131 19.099 9.612 8.399 17.582 30.939 30.188 114.419 122.160
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 419.203 euro in 2023 which includes Inventories of 0 euro, Receivables of 977 euro and cash availability of 418.225 euro.
The company's Equity was valued at 301.039 euro, while total Liabilities amounted to 122.160 euro. Equity increased by 150.561 euro, from 150.936 euro in 2022, to 301.039 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Dionamed Srl

Comments - Dionamed Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.